Drugs / Manganese Superoxide Dismutase Plasmid Liposome
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00618917 | Nov 2005 → Feb 2010 | esophageal disorder, poisoning | Joel Greenberger | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Manganese Superoxide Dismutase Plasmid Liposome | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00618917 ↗ |
| Route | Oral | “swallowed MnSOD plasmid/liposome (PL) transgene” NCT00618917 ↗ |